These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12102274)

  • 1. Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis.
    Marguerie L; Flipo RM; Grardel B; Beaurain D; Duquesnoy B; Delcambre B
    Joint Bone Spine; 2002 May; 69(3):275-81. PubMed ID: 12102274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis.
    O'Dell JR
    Rheum Dis Clin North Am; 1998 Aug; 24(3):465-77. PubMed ID: 9710881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid Arthritis Treatment After Methotrexate: The Durability of Triple Therapy Versus Etanercept.
    Peper SM; Lew R; Mikuls T; Brophy M; Rybin D; Wu H; O'Dell J
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1467-1472. PubMed ID: 28388820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.
    Capell HA; Madhok R; Porter DR; Munro RA; McInnes IB; Hunter JA; Steven M; Zoma A; Morrison E; Sambrook M; Wui Poon F; Hampson R; McDonald F; Tierney A; Henderson N; Ford I
    Ann Rheum Dis; 2007 Feb; 66(2):235-41. PubMed ID: 16926184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases.
    Ujfalussy I; Koó E; Seszták M; Gergely P
    Z Rheumatol; 2003 Apr; 62(2):155-60. PubMed ID: 12721703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients.
    Elkayam O; Yaron M; Zhukovsky G; Segal R; Caspi D
    Rheumatol Int; 1997; 17(2):49-53. PubMed ID: 9266620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriatic arthritis treatment and the risk of herpes zoster.
    Zisman D; Bitterman H; Shalom G; Feldhamer I; Comanesther D; Batat E; Greenberg-Dotan S; Cohen S; Cohen AD
    Ann Rheum Dis; 2016 Jan; 75(1):131-5. PubMed ID: 25261573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy.
    Wabe N; Wojciechowski J; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Proudman S; Wiese MD
    Int J Rheum Dis; 2017 Oct; 20(10):1447-1456. PubMed ID: 28952204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination therapy in rheumatoid arthritis].
    Johnsen V; Førre Ø; Haga HJ; Kvien TK; Mikkelsen K; Nordvåg BY; Rødevand E
    Tidsskr Nor Laegeforen; 2003 May; 123(11):1511-3. PubMed ID: 12822010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.
    de Jong PH; Hazes JM; Barendregt PJ; Huisman M; van Zeben D; van der Lubbe PA; Gerards AH; de Jager MH; de Sonnaville PB; Grillet BA; Luime JJ; Weel AE
    Ann Rheum Dis; 2013 Jan; 72(1):72-8. PubMed ID: 22679301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: a population-based retrospective cohort study.
    Tam HW; Chen CM; Leong PY; Chen CH; Li YC; Wang YH; Lin LC; Chiou JY; Wei JC
    Int J Rheum Dis; 2018 Aug; 21(8):1591-1599. PubMed ID: 29372595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial.
    Karstila KL; Rantalaiho VM; Mustonen JT; Möttönen TT; Hannonen PJ; Leirisalo-Repo M; Kaipiainen-Seppänen OA; Karjalainen AH; Korpela MM;
    Clin Exp Rheumatol; 2010; 28(1):73-8. PubMed ID: 20346242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis.
    Yan K; Zhang Y; Han L; Huang Q; Zhang Z; Fang X; Zheng Z; Yawalkar N; Chang Y; Zhang Q; Jin L; Qian D; Li X; Wu M; Xu Q; Zhang X; Xu J
    JAMA Dermatol; 2019 Mar; 155(3):327-334. PubMed ID: 30698628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis. epidemiology of DMARDs treatment in Japan.
    Nagashima M; Shu G; Yamamoto K; Yamahatsu S; Yoshino S
    Clin Exp Rheumatol; 2005; 23(1):27-35. PubMed ID: 15789884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined administration of long-acting antirheumatic drugs in the treatment of chronic polyarthritis].
    Wollenhaupt J; Zeidler H
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1219-23. PubMed ID: 9378046
    [No Abstract]   [Full Text] [Related]  

  • 18. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination therapy of disease-modifying antirheumatic drugs(DMARDs) in rheumatoid arthritis].
    Kobayashi S; Kanai Y
    Nihon Rinsho; 2002 Dec; 60(12):2351-6. PubMed ID: 12510361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
    Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
    Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.